Immuno-positron emission tomography (immunoPET) is a molecular imaging modality
combining the high sensitivity of PET with the specific targeting ability of monoclonal …

Pretargeted radioimmunodiagnosis and radioimmunotherapy aim to efficiently combine
antitumor antibodies and medicinal radioisotopes for high-contrast imaging and high …

Radioimmunoconjugates have been used for over 30 years in nuclear medicine
applications. In the last few years, advances in cancer biology knowledge have led to the …

The principle of pretargeted radioimmunoimaging and therapy has been investigated over
the past 30 y in preclinical and clinical settings with the aim of reducing the radiation burden …

Purpose An accurate diagnosis of colorectal carcinoma (CRC) can assist physicians in
developing reasonable therapeutic regimens, thereby significantly improving the patient's …

Advancements in monitoring and predicting of patient-specific response of triple negative
breast cancer (TNBC) to immunotherapy (IMT) with and without chemotherapy are needed …

Pretargeting parameters for the use of anti–carcinoembryonic antigen (CEA) bispecific
monoclonal antibody TF2 and the 68Ga-labeled IMP288 peptide for immuno-PET have …

Introduction This pilot study evaluated the imaging performance of pretargeted
immunological positron emission tomography (immuno-PET) using an anti …

There are no effective treatment options for most patients with metastatic colorectal cancer
(mCRC). mCRC remains a leading cause of tumor-related death, with a five-year survival …

Pretargeted positron emission tomography is a macromolecule-driven nuclear medicine
technique that involves targeting a preadministered antigen target-bound macromolecule …